Self-directed peptide use can also be risky for patients taking multiple medications, patients with liver or kidney concerns, people with bleeding disorders, and anyone who has experienced unusual reactions to injectable products
Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Atkin SL, Al-Rasadi K, et al
Youll typically face: Copays ranging from $25-$100 per month with commercial insurance Prior authorization requirements showing youve tried other diabetes medications first Step therapy protocols requiring failure on metformin or other first-line treatments Quantity limits restricting how much you can fill at once Even with insurance coverage for diabetes, many plans implement these barriers that can delay access to the medication for weeks or months
Gradual dose titration can improve tolerability
Our experience shows Mississippi patients often discover telehealth compounding only after their retail pharmacy goes on backorder for Wegovy